#Tinea Pedis Treatment Market

[rahulp3]

Tinea Pedis Treatment Market Outlook 2022 Growth Strategy, Future Trends, Analysis by Type, Application, End User, and Business Opportunities to 2032

The global tinea pedis treatment market is expected to reach US$ 1.35 Billion in 2022, and further expand at a CAGR rate of 5.2% to surpass ~US$ 2.24 Billion by the end of 2032. In terms of disease indication, the interdigital tinea pedis treatment market is expected to lead with a share of about 68.3% in 2022.

Focus of government on prevention of diseases to curb healthcare costs; entry into untapped markets to present opportunities for growth

Tinea infections are fungal infections caused by T rubrum, Trichophyton mentagrophytes and Epidermophyton floccosum. This dermatophyte fungus thrives in humid conditions. The clinical features of tinea pedis include patchy and dry scaling on foot and presence of blisters or pustules on feet and between toes. Various countries are focusing on prevention of microbial and fungal diseases to reduce their healthcare costs, which in turn, is expected to result in high demand for advanced treatment options and diagnostic processes from local governments and third-party payers.

Moreover, increasing research and development activities to develop highly specific antifungal products are also expected to create new growth opportunities for manufacturers operating in tinea pedis treatment market. Currently, several countries are still unaware about fungal treatment. In several low income countries, physicians depend on antibacterial treatment and steroids for the treatment process. Awareness about effective treatment procedures in these countries is very low. However, these countries have a large patient pool and hence, various companies are trying to enter into these markets by offering better quality and affordable antifungal products.

Download a PDF of Most recent Reports and market treads @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2084

Insights on the global tinea pedis treatment market

Future Market Insights in its research report on the global tinea pedis treatment market has described a complete market scenario and has presented forecast insights on the global market for tinea pedis treatment for a period of 10 years. According to Future Market Insights, the global tinea pedis treatment market is expected to grow at a moderate rate to register a CAGR of 4.8% throughout the period of forecast, 2017-2027. The estimation value of global tinea pedis treatment market is bit more than US$ 1 Bn in 2017 and is anticipated to touch a value more than US$ 1700 Mn by the end of 2027. The growth of the global tinea pedis treatment market can be attributed towards increasing geriatric population, rising consumer inclination towards maintaining aesthetic appearance, increasing product innovation and rising per capita healthcare expenditure.

Increasing occurrence of interdigital tinea pedis to augment the demand for the treatment of the disease in the coming years

Typically, tinea pedis occurs in the form of interdigital spaces. The occurrence of interdigital tinea pedis is higher than other type of tinea pedis diseases. This has led to an increased focus on the treatment of interdigital tinea pedis. The interdigital tinea pedis segment in the disease type category is the largest segment owing to higher prevalence of the disease. The interdigital tinea pedis segment is expected to grow at a CAGR of 4.5% throughout the period of forecast and is expected to generate a value of more than US$ 1.1 Bn by the end of 2027. In 2017, it is valued at less than US$ 750 Mn. This segment is expected to dominate the global market by disease type.

Plantar tinea pedis, also known as moccasin foot, occurs on the side of the foot. The plantar tinea pedis segment is anticipated to grow at a significant rate to reach an estimation of around US$ 320 Mn by the end of the year of assessment. This is the second largest segment in terms of value as well as growth rate. It is projected to register a CAGR of 5.1% during the period of forecast, 2017-2027.

Major segment covered:-

Disease Indication

Route of Administration

Distribution Channel

Drug Class and Region

Key Market Segments Covered in Tinea Pedis Treatment Industry Research

By Disease Indication:

Interdigital Tinea Pedis

Plantar Tinea Pedis

Vesicular Tinea Pedis

By Route of Administration:

Topical

Gel

Cream

Spray

Lotion

Powder

Oral

By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Drug Stores

Online Pharmacies

By Drug Class:

Antifungals

Combination

[peeterdbmr]

Tinea pedis or Athlete’s foot is a contagious fungal infection usually begins between the toes. It can also spread into toe nails and hands. This infection occurs by sweating in feet while usage of tight fitting shoes. It can be characterized by skin fissures or red and itchy skin scales.

[marketsresearchdbmr]

Tinea pedis or Athlete’s foot is a contagious fungal infection usually begins between the toes. It can also spread into toe nails and hands. This infection occurs by sweating in feet while usage of tight fitting shoes. It can be characterized by skin fissures or red and itchy skin scales.

[kelvindbmr]

Tinea pedis or Athlete’s foot is a contagious fungal infection usually begins between the toes. It can also spread into toe nails and hands. This infection occurs by sweating in feet while usage of tight fitting shoes. It can be characterized by skin fissures or red and itchy skin scales.

[newsinsights]

According to Future Market Insights, the global tinea pedis treatment market is expected to grow at a moderate rate to register a CAGR of 4.8% throughout the period of forecast, 2017-2027.         The estimation value of global tinea pedis treatment market is bit more than US$ 1 Bn in 2017 and is anticipated to touch a value more than US$ 1700 Mn by the end of 2027

[siemenlee]

Tinea pedis or Athlete’s foot is a contagious fungal infection usually begins between the toes. It can also spread into toe nails and hands. This infection occurs by sweating in feet while usage of tight fitting shoes. It can be characterized by skin fissures or red and itchy skin scales.

[nileshdbmr]

Global tinea pedis treatment market is rising gradually with a substantial CAGR of 3.9% in the forecast period of 2020-2027. The report contains data of the base year 2019 and historic year 2018. Prevelance of tinea pedis amongst the population contributes towards this market growth.

[medicalnewstoday]

Global Tinea Pedis Treatment Market research to Make Great Impact in Near Future by 2017 - 2027

Description of the research supporting your decision in investing in the report

The extensive research report titled “Tinea Pedis Treatment Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)” crafted by Market Insights assists the reader in compiling and slating key growth strategies with a view to maintain correct growth rhythm in spite of the changing market dynamics in the current as well as in the future. Analysis on each segment of the market is included and assessment of these segments across key region in the globe is presented in a methodical format in the report.

The research reflects the global market view in a nutshell

The research report on tinea pedis treatment market covers various trends, opportunities, developments, drivers and restraints influencing the growth of the global market. These aspects are studied across key regional markets and their intensity is assessed from which the current and future market scenario is gauged. The statistics and data supporting these predictions are arranged in an orderly manner convenient for the reader to use. All the statistics are obtained keeping an unbiased view into consideration thus emphasizing on the authenticity of the research report. Moreover, deep diving in the segments along with a strong data mining process enables to sketch the possible future market direction and a complete scenario of the global tinea pedis treatment market with valuable acumen to offer need based solutions. The research on the global tinea pedis treatment market is carried out keeping a predefined purpose having clarity about the market, and involves appropriate statistical data based on a clear market definition.

Get Sample Copy of this report @ https://www.xploremr.com/connectus/sample/867

The research follows a strong research methodology

Primary research and secondary research are used to glean relevant insights of the global tinea pedis treatment market. The research process includes several funnels of validation of the data to take the numbers to almost 100 percent accuracy. The data point associated with each segment is cross verified during every level of the primary research. Additionally, opinions from subject matter experts and market observers is also collated and with the help of triangulation method, data pertaining to respective market segments is obtained that radiates high precision.

In-depth five level market segmentation

The research report on global tinea pedis treatment market covers an in-depth market segmentation that covers every angle of the market.

By Disease Type

Interdigital Tinea Pedis

Plantar Tinea Pedis

Vesicular Tinea Pedis

By Drug Class

Antifungals

Steroids and Anti-Infective Combinations

Request for Check Discount @ https://www.xploremr.com/connectus/check-discount/867

By Route of Administration

Topical

Gel

Cream

Spray

Lotion

Powder

Oral

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Drug Stores

Online Pharmacies

By Region

North America

Latin America

Western Europe

Eastern Europe

Asia Pacific excluding Japan (APEJ)

Japan

Middle East and Africa (MEA)

The report covers weighted analysis of the competition scenario

The research report also includes a separate section focusing on the key players within the market. This section, called competitive analysis, uncovers all the major facts about the key companies involved in the activities pertaining to the global tinea pedis treatment market. Their product portfolio analysis, pricing strategies, marketing strategies, promotion tactics, expansion plans, regional spread, major developments and key innovations, mergers and acquisitions, important strategies, revenue, market shares, key personnel, other key financials etc., is included in this report that can give the reader a broad idea about the activities in the market based on which next moves can be planned. The companies included in this section are those which have enormous hold on the market and studying their tactics can definitely help the upcoming players to move up the ladder accomplishing their respective milestones.

Request Methodology of this report @ https://www.xploremr.com/connectus/request-methodology/867

About us: XploreMR is one of the world’s leading resellers of high-quality market research reports. We feature in-depth reports from some of the world’s most reputed market research companies and international organizations. We serve across a broad spectrum – from Fortune 500 to small and medium businesses. Our clients trust us for our unwavering focus onquality and affordability. We believe high price should not be a bottleneck for organizations looking to gain access to quality information. Our team comprises an eclectic mix of experienced market research specialists, search engine specialists, web designers, online marketers, and business writers. The team is highly committed to going above and beyond, and serving the research needs of our clientele. Contact us:

111 North Market Street, Suite 300, San Jose, CA 95113, United States Tel: +1-669-284-0108 E-mail: sales@xploremr.com Website: www.xploremr.com

[lilywhiteflower-blog]

Tinea Pedis Treatment Market - Competitive Landscape Analysis with Forecast by 2025

Global Tinea Pedis Treatment Market: Snapshot

Athlete's foot known medically as tinea pedis, is a common skin infection of the feet caused by various kinds of fungi. Signs and symptoms often include itching, scaling, cracking and redness. In rare cases, the skin may blister. Athlete's foot fungus may infect any part of the foot, but most often grows between the toes. Apart from these areas, the fungus might develop at the bottom of the foot, under nails, on hands, and nearby skin areas.

Tinea pedis is a member of the group of diseases known as tinea, and is mainly caused by a number of different fungi.  Trichophyton, Epidermophyton, and Microsporum, are some of the major fungi types that may cause the tinea pedis ailment. The condition is typically acquired by coming into contact with infected skin or also with the fungi type mentioned above from the environment. Common places where the fungi can survive are around swimming pools and in locker rooms; they may also be spread from other animals. Usually diagnosis is made on the basis of signs and symptoms; however, it can be confirmed either by studying cultures or by observing hyphae using a microscope.

Some methods of prevention include avoiding walking barefoot in public showers, keeping toenails short, wearing clean shoes, and changing socks daily. When infected, the feet should be kept dry and clean, and wearing sandals or floaters may help. Treatment can either be carried out with antifungal medication applied to the skin such as clotrimazole. For persistent infections, medication such as terbinafine need to be administered through the oral cavity. The use of these medicines is typically recommended for four weeks.

Globally, athlete's foot affects about 15% of the population, and males are more often affected than females. It occurs most frequently in older children or younger adults. Historically, the disease is believed to have been a rare condition and was more frequent in the 1900s.

Request Sample Copy of the Report @

https://www.tmrresearch.com/sample/sample?flag=B&rep_id=3329

Global Tinea Pedis Treatment Market: Overview

The global market for tinea pedis treatment has expanded on account of the rising awareness about skin infections and diseases amongst people. Tinea pedis, or Athlete’s foot, is a skin infection of the feet that is caused by fungus, and it results in excessive itching around the affected area.  The discomfort caused by tinea pedis can become unbearable for the sufferers, and hence, it is important to initiate immediate treatment once the symptoms start showing. Fungus can be acquired from multiple sources including public showers, filth deposits, unclean shoes or socks, and by coming in direct contact with an affected person. For sportspersons and athletes, it is important to avoid infections to retain their performance, which contributes to the demand for tinea pedis treatment. On the contrary, sportspersons and athletes are the most prone to acquiring skin infections either due to excessive sweating or by using shared toiletries, towels, and other essentials. Hence, the global market for tinea pedis treatment has attracted commendable demand due to increased uptake of sports and strenuous activities.

The global market for tinea pedis treatment may be classified based on the following parameters: diseases type, drug class, route of administration, distribution channel, and region. It is important to analyze each of the aforementioned segments to get a wider purview of the market.

The report is a descriptive portrayal of the forces operating in the global market for tinea pedis treatment. In order to get a wider view of the market, the researchers of the report have analyzed the demographics of the possible consumers in the market.

Request TOC of the Report @

https://www.tmrresearch.com/sample/sample?flag=T&rep_id=3329

Global Tinea Pedis Treatment Market: Trends and Opportunities

The dermatophyte fungus that causes tinea pedis grows under humid conditions, and hence, people living in the humid areas are at a greater risk of acquiring the infection. Governments across several regions have made ardent efforts to prevent the prevalence of tinea pedis which has propelled demand within the global market. Moreover, the contagious nature of the infection has led dermatologists to educate and inform patients about the importance of proper treatment. This has also contributed towards aiding the growth of the global market for tinea pedis treatment. The quest of certain countries to eliminate the possibility of fungal and microbial diseases has also propelled demand within the global market for tinea pedis. Despite the aforementioned drivers of demand, a number of countries are still far from devising ways to eliminate or treat fungal infections. Nevertheless, the research and development initiatives in the field of dermatology are expected to trickle down to the impoverished nations, which is expected to generate demand in these regions.

Global Tinea Pedis Treatment Market: Regional Outlook

The global market for tinea pedis is expected to be reigned by North America in terms of market share. The prominence of the research and development initiatives in North America is the primary reason behind the growth of the regional market. The European market is also expected to exhibit a trend of positive growth over the forthcoming years. 

Global Tinea Pedis Treatment Market: Competitive Landscape

Some of the leading players in the global market for tinea pedis are GSK, Viamet Pharmaceuticals Exeltis USA, and Valeant. All of these market players are expected to concentrate on key product innovations over the course of the next few years.

Read Comprehensive Overview of Report @

https://www.tmrresearch.com/tinea-pedis-treatment-market

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

TMR Research, 3739 Balboa St # 1097, San Francisco, CA 94121 United States Tel: +1-415-520-1050

[priyankaganguly-blog]

Tinea Pedis Treatment Market – Competitive Outlook on Dominating Players 2025

Global Tinea Pedis Treatment Market: Snapshot

Athlete's foot known medically as tinea pedis, is a common skin infection of the feet caused by various kinds of fungi. Signs and symptoms often include itching, scaling, cracking and redness. In rare cases, the skin may blister. Athlete's foot fungus may infect any part of the foot, but most often grows between the toes. Apart from these areas, the fungus might develop at the bottom of the foot, under nails, on hands, and nearby skin areas.

Request Sample Copy of the Report @

https://www.tmrresearch.com/sample/sample?flag=B&rep_id=3329

Tinea pedis is a member of the group of diseases known as tinea, and is mainly caused by a number of different fungi.  Trichophyton, Epidermophyton, and Microsporum, are some of the major fungi types that may cause the tinea pedis ailment. The condition is typically acquired by coming into contact with infected skin or also with the fungi type mentioned above from the environment. Common places where the fungi can survive are around swimming pools and in locker rooms; they may also be spread from other animals. Usually diagnosis is made on the basis of signs and symptoms; however, it can be confirmed either by studying cultures or by observing hyphae using a microscope.

Some methods of prevention include avoiding walking barefoot in public showers, keeping toenails short, wearing clean shoes, and changing socks daily. When infected, the feet should be kept dry and clean, and wearing sandals or floaters may help. Treatment can either be carried out with antifungal medication applied to the skin such as clotrimazole. For persistent infections, medication such as terbinafine need to be administered through the oral cavity. The use of these medicines is typically recommended for four weeks.

Request TOC of the Report @

https://www.tmrresearch.com/sample/sample?flag=T&rep_id=3329

Globally, athlete's foot affects about 15% of the population, and males are more often affected than females. It occurs most frequently in older children or younger adults. Historically, the disease is believed to have been a rare condition and was more frequent in the 1900s.

Global Tinea Pedis Treatment Market: Overview

The global market for tinea pedis treatment has expanded on account of the rising awareness about skin infections and diseases amongst people. Tinea pedis, or Athlete’s foot, is a skin infection of the feet that is caused by fungus, and it results in excessive itching around the affected area.  The discomfort caused by tinea pedis can become unbearable for the sufferers, and hence, it is important to initiate immediate treatment once the symptoms start showing. Fungus can be acquired from multiple sources including public showers, filth deposits, unclean shoes or socks, and by coming in direct contact with an affected person. For sportspersons and athletes, it is important to avoid infections to retain their performance, which contributes to the demand for tinea pedis treatment. On the contrary, sportspersons and athletes are the most prone to acquiring skin infections either due to excessive sweating or by using shared toiletries, towels, and other essentials. Hence, the global market for tinea pedis treatment has attracted commendable demand due to increased uptake of sports and strenuous activities.

The global market for tinea pedis treatment may be classified based on the following parameters: diseases type, drug class, route of administration, distribution channel, and region. It is important to analyze each of the aforementioned segments to get a wider purview of the market.

The report is a descriptive portrayal of the forces operating in the global market for tinea pedis treatment. In order to get a wider view of the market, the researchers of the report have analyzed the demographics of the possible consumers in the market.

Global Tinea Pedis Treatment Market: Trends and Opportunities

The dermatophyte fungus that causes tinea pedis grows under humid conditions, and hence, people living in the humid areas are at a greater risk of acquiring the infection. Governments across several regions have made ardent efforts to prevent the prevalence of tinea pedis which has propelled demand within the global market. Moreover, the contagious nature of the infection has led dermatologists to educate and inform patients about the importance of proper treatment. This has also contributed towards aiding the growth of the global market for tinea pedis treatment. The quest of certain countries to eliminate the possibility of fungal and microbial diseases has also propelled demand within the global market for tinea pedis. Despite the aforementioned drivers of demand, a number of countries are still far from devising ways to eliminate or treat fungal infections. Nevertheless, the research and development initiatives in the field of dermatology are expected to trickle down to the impoverished nations, which is expected to generate demand in these regions.

Read Comprehensive Overview of Report @

https://www.tmrresearch.com/tinea-pedis-treatment-market

Global Tinea Pedis Treatment Market: Regional Outlook

The global market for tinea pedis is expected to be reigned by North America in terms of market share. The prominence of the research and development initiatives in North America is the primary reason behind the growth of the regional market. The European market is also expected to exhibit a trend of positive growth over the forthcoming years. 

Global Tinea Pedis Treatment Market: Competitive Landscape

Some of the leading players in the global market for tinea pedis are GSK, Viamet Pharmaceuticals Exeltis USA, and Valeant. All of these market players are expected to concentrate on key product innovations over the course of the next few years.

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

TMR Research,

3739 Balboa St # 1097,

San Francisco, CA 94121

United States

Tel: +1-415-520-1050

Email: sales@tmrresearch.com

[pressreleaseng-blog]

Tinea Pedis Treatment Market Volume Analysis, Segments, Value Share and Key Trends 2016-2026

Tinea Pedis Treatment Market Volume Analysis, Segments, Value Share and Key Trends 2016-2026

Tinea Pedis also called as Athlet’s Foot is a superficial fungal infection of feet caused by group of fungi known as dermatophytes. Fungi are eukaryotic organism that live as saprophyte or parasite existing in two different forms as yeast and molds. Moist, occlusive environment is the ideal environment for the growth of such organism affecting keratin of the top layer of the epidermis. Conditions…

[marketupdates]

Tinea Pedis Treatment Market to Grow at a CAGR of 3.2% During the Forecast Period 2020-2025

Tinea Pedis Treatment Market size is $929.01m in 2019, and is estimated grow at a CAGR of 3.2% during the forecast period 2020-2025.

[peeterdbmr]

Tinea pedis or Athlete’s foot is a contagious fungal infection usually begins between the toes. It can also spread into toe nails and hands. This infection occurs by sweating in feet while usage of tight fitting shoes. It can be characterized by skin fissures or red and itchy skin scales.

[vicky8588]

Bovine Lactoferrin Market, Size, Share, Growth, Trends 2021-2028

Market Overview

The global bovine lactoferrin market size was valued at US$ YY million in 2020 and is estimated to reach US$ YY million by 2028, growing at a CAGR of YY % during the forecast period (2021-2028). 

Lactoferrin protein can be found in both human and cow milk. Bovine lactoferrin (bLF) has been shown to have anti-infective, anti-cancer, and anti-inflammatory properties when consumed. Oral bLF, in particular is effective against infections of both digestive and non-digestive tract tissue in a variety of animal models.

Download Free Sample: https://www.datamintelligence.com/download-sample/bovine-lactoferrin-market

Market Dynamics

The development of the immune system and the benefits associated with bovine lactoferrin are estimated to drive the market.

The development of the immune system is estimated to drive the bovine lactoferrin market

Lactoferrin is regarded to be the most polyvalent protein in vertebrate tissue defence against infections and traumas. It possesses antibacterial capabilities and affects innate and adaptive immune responses due to the proclivity of its basic N-terminal domain to interact with multiple microbial and host targets. Lactoferrin can influence immune cell activation, migration, and proliferation in both positive and negative ways. While lactoferrin's immunomodulatory effects have been demonstrated in vivo utilising lactoferrin deletion, lactoferrin-overexpressing transgenic animals, and dietary lactoferrin, few pathways have been postulated on in vitro research.

While lactoferrin's immunomodulatory effects have been demonstrated in vivo utilising lactoferrin deletion, lactoferrin-overexpressing transgenic mice, and dietary lactoferrin, few mechanisms have been proposed to explain these properties based on in vitro research. Recent studies in humans provided evidence that oral supplementation with lactoferrin contributed to immune stimulation. The lactoferrin-based product increases immunological activities via inducing TGF and Wnt signalling pathways, as well as many genes encoding molecular effectors involved in the innate immune response, according to the study. Lysozymes (which mediate antibacterial defence by cleaving bacterial cell walls), saposins (peptides with antibacterial activity that create ion channels in target cell membranes), and lectins are all members of this gene family (proteins involved in pathogen detection).

The benefits associated with the use of bovine lactoferrin is estimated to drive the market

Bovine lactoferrin (bLF) has been shown to have anti-infective, anti-cancer, and anti-inflammatory properties when consumed. Oral bLF, in particular has shown to be effective against infections of both digestive and non-digestive tract tissue in a variety of animal models. Furthermore, clinical trials on individuals with Helicobacter pylori infection, chronic hepatitis, tinea pedis, and other disorders have shown that bLF has beneficial effects. Immunomodulation in the intestinal and systemic locations may mediate the protective effects of oral bLF against infection.

 Recently it was established that oral bLF has antiviral properties in influenza virus-infected mice. The amount of infiltrating leukocytes in the bronchoalveolar lavage fluid was reduced after BLF treatment. Using the quantitative RT-PCR method, oral bLF on the transcription of genes associated with immunity in the small intestine of mice was studied. The expression of IL-12p40, IFN-beta, and NOD2 was observed to be elevated after consuming bLF. As a result, oral bLF promotes the transcription of key immune-related genes in the small intestine, potentially promoting systemic host immunity.

Side effects associated with lactoferrin is estimated to hamper the bovine lactoferrin market

Lactoferrin, in the amounts found in food, is likely safe. Consuming larger levels of lactoferrin up to a year from cow's milk is possibly safe. For up to 14 days, human lactoferrin generated from specifically processed rice appears to be safe. Lactoferrin has the potential to cause diarrhoea. Skin rash, loss of appetite, weariness, cold, and constipation have all been recorded in high doses.

High amounts of lactoferrin can cause diarrhoea, chills, weariness, loss of appetite, and constipation, among other things. People are concerned about mad cow disease since lactoferrin can be obtained from cows. The proper daily dosage of derived from dietary supplements is between 10 and 1200mg. To be safe, seek advice from a healthcare practitioner about a dosage that is appropriate for particular age, health state, and nutritional requirements.

COVID-19 Impact Analysis

Lactoferrin (LF) is a harmless iron-binding glycoprotein found in the milk of most animals. It has antiviral activity across a wide range of viruses, including coronaviruses. LF also has anti-inflammatory, anti-infective, and immune-regulating capabilities in line with SARS-CoV-2 infection therapy requirements. As a result, LF may be useful in the prevention and treatment of COVID-19. Furthermore, compared with other antiviral drugs, LF has a better safety profile. The use of LF may therefore hold promising results in the treatment of COVID-19 and warrants further investigation. Hence, there is an estimated scope for it in the market.

Segment Analysis

By Type

·       Spay dried powder*

·       Freeze dried powder

By Application

·       Infant formula*

·       Dietary supplements

·       Pharmaceutical

·       Others

Geographical Analysis

North America region is estimated to dominate the bovine lactoferrin market

The FDA approval and presence of major key players in this region are estimated to dominate the market.

The US FDA recently cleared lactoferrin for use in infant formula. The demand value of U.S. lactoferrin was about 57.26 tons and is forecasted to increase to about 111.8 tons by 2025. Bovine lactoferrin (bLf) concentration in milk is normally about 100 mg/L (with the range of 70–120 mg/L). Owing to the availability of many cows in this region, the supply of bovine lactoferrin will be more. In the 24 major states the number of milk cows on farms was 8.94 million head 88,000 head more than February 2020, and 2,000 head more than January 2021. In the United States the number of milk cows on farms was 9.46 million, 81,000 head more than February 2020 and 3,000 head more than January 2021. Hence, this region is estimated to dominate the market due to the presence of many cows.

Competitive Landscape

Major key players present in the global bovine lactoferrin market are Fonterra Group, Bega Cheese, FrieslandCampina (DMV), Milei Gmbh, Glanbia Nutritionals, Westland Milk, Tatua, Synlait Milk, WBC, Murray Goulburn and Ingredia Nutritional

Fonterra Group

Overview: Fonterra Cooperative Group is the world's largest dairy exporter, a leader in dairy research and innovation, the owner of a considerable portfolio of Asian Pacific brands, and a partner to many of the world's leading food companies. Fonterra has offices in more than 40 countries across the world with its headquarters in New Zealand.

Product Portfolio: The company comprises Dairy, Nutrition and Dairy Ingredients.

Key Development: In 2020, Fonterra Australia signed an agreement to buy Dairy Country to help the company's premier Australian cheese division become more efficient.

View Full Report: https://www.datamintelligence.com/research-report/bovine-lactoferrin-market

Enquiry Before Buying: https://www.datamintelligence.com/enquiry/bovine-lactoferrin-market

About Us 

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world.

 For more information: 

Sai Kiran

Sales Manager at DataM Intelligence

Email: info@datamintelligence.com

Tel: +1 877 441 4866

Website: www.datamintelligence.com